LevocarnitineAlternative Names: L-carnitine
Latest Information Update: 12 Feb 2016
At a glance
- Originator Shiner Pharm Corp
- Class Amino acids
- Mechanism of Action Carnitine acetyltransferase stimulants; Free radical scavengers; Pyruvate dehydrogenase kinase stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Metabolic disorders
Most Recent Events
- 12 Feb 2016 Launched for Metabolic disorders in Taiwan (IV) before February 2016